S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks
S&P 500   5,123.41
DOW   37,983.24
QQQ   441.74
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Stock market today: Wall Street gains ahead of earnings, oil falls as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
Did You Miss the Gold Rush? Try These 2 Silver Stocks

TScan Therapeutics (TCRX) Short Interest Ratio & Short Volume

$7.75
-0.05 (-0.64%)
(As of 04/12/2024 06:55 PM ET)

TScan Therapeutics Short Interest Data

Current Short Volume
219,400 shares
Previous Short Volume
188,300 shares
Change Vs. Previous Month
+16.52%
Dollar Volume Sold Short
$1.74 million
Short Interest Ratio / Days to Cover
1.3
Last Record Date
March 31, 2024
Outstanding Shares
47,880,000 shares
Float Size
36,440,000 shares
Short Percent of Float
0.60%
Today's Trading Volume
128,900 shares
Average Trading Volume
166,945 shares
Today's Volume Vs. Average
77%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TScan Therapeutics ?

Sign up to receive the latest short interest report for TScan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TCRX Short Interest Over Time

TCRX Days to Cover Over Time

TCRX Percentage of Float Shorted Over Time

TScan Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024219,400 shares $1.74 million +16.5%0.6%1.3 $7.94
3/15/2024188,300 shares $1.34 million +0.3%0.5%1.2 $7.12
2/29/2024187,700 shares $1.27 million -25.8%0.5%1.2 $6.75
2/15/2024252,900 shares $1.45 million +3.8%0.7%1.6 $5.74
1/31/2024243,600 shares $1.24 million -6.4%0.6%1.8 $5.11
1/15/2024260,300 shares $1.56 million -14.6%0.7%2 $6.00
12/31/2023304,700 shares $1.78 million -14.1%0.8%2.3 $5.83
12/15/2023354,700 shares $1.76 million -5.0%0.9%3.1 $4.95
11/30/2023373,300 shares $2.44 million -10.3%1.0%3.1 $6.53
11/15/2023416,000 shares $1.98 million -11.6%1.1%3.5 $4.76
10/31/2023470,700 shares $1.81 million -10.5%1.2%4.4 $3.85
10/15/2023526,000 shares $1.77 million -7.2%1.4%5.1 $3.37
9/30/2023566,900 shares $1.45 million +50.5%1.5%4.7 $2.56
9/15/2023376,800 shares $1.09 million +12.5%1.0%2.9 $2.89
8/31/2023334,800 shares $796,824.00 -5.0%0.9%2.5 $2.38
8/15/2023352,300 shares $739,830.00 -9.8%0.9%1.4 $2.10
7/31/2023390,700 shares $875,168.00 +9.0%0.9%0.3 $2.24
7/15/2023358,400 shares $756,224.00 -5.6%0.8%0.2 $2.11
6/30/2023379,600 shares $949,000.00 -5.6%0.9%0.3 $2.50
6/15/2023401,900 shares $1.09 million -19.6%1.0%0.3 $2.72
5/31/2023499,900 shares $1.15 million +19.8%1.4%0.4 $2.30
5/15/2023417,400 shares $1.68 million +365.9%2.9%0.3 $4.03
4/30/202389,600 shares $203,392.00 -2.3%0.7%0.1 $2.27
4/15/202391,700 shares $200,823.00 -24.7%0.7%0.6 $2.19
3/31/2023121,700 shares $255,570.00 -21.0%0.9%0.8 $2.10
3/15/2023154,000 shares $403,480.00 -2.0%1.2%1 $2.62
2/28/2023157,100 shares $463,445.00 +4.0%1.2%1 $2.95
2/15/2023151,000 shares $407,700.00 -50.3%1.2%1 $2.70
1/31/2023303,800 shares $552,916.00 +109.7%3.3%2.2 $1.82
1/15/2023144,900 shares $318,780.00 -1.6%1.6%1.1 $2.20
12/30/2022147,200 shares $228,160.00 +1.1%1.6%5.8 $1.55
12/15/2022145,600 shares $276,640.00 -5.9%1.6%7.4 $1.90
11/30/2022154,800 shares $334,368.00 -3.9%1.7%8.5 $2.16
11/15/2022161,000 shares $431,480.00 +14.9%1.8%8.5 $2.68
10/31/2022140,100 shares $378,270.00 +151.5%1.5%7.3 $2.70
10/15/202255,700 shares $167,100.00 -7.0%0.6%2.6 $3.00
9/30/202259,900 shares $182,695.00 +12.6%0.7%3 $3.05
9/15/202253,200 shares $173,432.00 +731.3%0.6%2.5 $3.26
8/31/20226,400 shares $17,600.00 -96.8%0.1%0.3 $2.75
8/15/2022202,300 shares $681,751.00 +12.3%2.2%9.9 $3.37
Bitcoin’s All Time High Is Just the Beginning (Ad)

Bitcoin has officially hit a new all-time high. But if you think you’re too late… Think again.

This Crypto bull market is not even halfway over

TCRX Short Interest - Frequently Asked Questions

What is TScan Therapeutics' current short interest?

Short interest is the volume of TScan Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 219,400 shares of TCRX short. 0.60% of TScan Therapeutics' shares are currently sold short. Learn More on TScan Therapeutics' current short interest.

What is a good short interest ratio for TScan Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRX shares currently have a short interest ratio of 1.0. Learn More on TScan Therapeutics's short interest ratio.

What is a good short interest percentage for TScan Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.60% of TScan Therapeutics' floating shares are currently sold short.

Is TScan Therapeutics' short interest increasing or decreasing?

TScan Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 219,400 shares, an increase of 16.5% from the previous total of 188,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TScan Therapeutics' float size?

TScan Therapeutics currently has issued a total of 47,880,000 shares. Some of TScan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TScan Therapeutics currently has a public float of 36,440,000 shares.

How does TScan Therapeutics' short interest compare to its competitors?

0.60% of TScan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TScan Therapeutics: Tenaya Therapeutics, Inc. (4.99%), Lexeo Therapeutics, Inc. (4.88%), Invivyd, Inc. (3.85%), Anavex Life Sciences Corp. (26.94%), Humacyte, Inc. (4.62%), MeiraGTx Holdings plc (1.79%), ProKidney Corp. (31.25%), Aura Biosciences, Inc. (6.17%), SOPHiA GENETICS SA (0.11%), Monte Rosa Therapeutics, Inc. (5.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short TScan Therapeutics stock?

Short selling TCRX is an investing strategy that aims to generate trading profit from TScan Therapeutics as its price is falling. TCRX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TScan Therapeutics?

A short squeeze for TScan Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRX, which in turn drives the price of the stock up even further.

How often is TScan Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRX, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TCRX) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners